(PINC) Premier - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74051N1028

Group Buying, Software Analytics

PINC EPS (Earnings per Share)

EPS (Earnings per Share) of PINC over the last years for every Quarter: "2020-09": 0.57, "2020-12": 0.65, "2021-03": 0.64, "2021-06": 0.6, "2021-09": 0.64, "2021-12": 0.73, "2022-03": 0.57, "2022-06": 0.61, "2022-09": 0.52, "2022-12": 0.72, "2023-03": 0.58, "2023-06": 0.68, "2023-09": 0.54, "2023-12": 0.6, "2024-03": 0.55, "2024-06": 0.69, "2024-09": 0.34, "2024-12": 0.25, "2025-03": 0.44, "2025-06": 0.43, "2025-09": 0,

PINC Revenue

Revenue of PINC over the last years for every Quarter: 2020-09: 346.887, 2020-12: 422.827, 2021-03: 469.923, 2021-06: 481.515, 2021-09: 365.147, 2021-12: 379.215, 2022-03: 347.833, 2022-06: 340.706, 2022-09: 313.873, 2022-12: 359.626, 2023-03: 322.232, 2023-06: 340.364, 2023-09: 318.752, 2023-12: 334.745, 2024-03: 286.866, 2024-06: 350.268, 2024-09: 248.142, 2024-12: 240.266, 2025-03: 261.382, 2025-06: 262.857, 2025-09: null,

Description: PINC Premier

Premier Inc (NASDAQ:PINC) is a US-based healthcare services company. As a leading healthcare services provider, the companys performance is closely tied to the overall healthcare landscape, including trends in healthcare spending, regulatory changes, and shifts in care delivery models.

Key drivers of PINCs financial performance include revenue growth, driven by the companys ability to expand its services and customer base, as well as its ability to manage costs and maintain profitability. Return on Equity (ROE) of 3.49% suggests that the company is generating relatively modest returns for shareholders, potentially indicating a need for improvement in capital allocation or profitability.

The stocks valuation, as reflected in its Price-to-Earnings (P/E) ratio of 21.10 and Forward P/E of 15.17, suggests that investors have moderate expectations for the companys future earnings growth. The relatively low Beta of 0.545 indicates that PINCs stock price tends to be less volatile than the broader market, potentially making it a more attractive option for risk-averse investors.

To drive future growth, PINC will likely need to focus on expanding its services, improving operational efficiency, and navigating the complex healthcare regulatory environment. Key Performance Indicators (KPIs) to watch include revenue growth rate, customer acquisition costs, and operating margin expansion. Additionally, the companys ability to adapt to changes in healthcare policy and reimbursement rates will be critical to its long-term success.

PINC Stock Overview

Market Cap in USD 2,299m
Sub-Industry Health Care Services
IPO / Inception 2013-09-26

PINC Stock Ratings

Growth Rating 7.06%
Fundamental 49.2%
Dividend Rating 71.5%
Return 12m vs S&P 500 30.9%
Analyst Rating 2.88 of 5

PINC Dividends

Dividend Yield 12m 3.00%
Yield on Cost 5y 2.80%
Annual Growth 5y 21.93%
Payout Consistency 99.2%
Payout Ratio 57.5%

PINC Growth Ratios

Growth Correlation 3m 96.6%
Growth Correlation 12m 59.1%
Growth Correlation 5y -74.2%
CAGR 5y -3.11%
CAGR/Max DD 3y (Calmar Ratio) -0.07
CAGR/Mean DD 3y (Pain Ratio) -0.11
Sharpe Ratio 12m -0.13
Alpha 40.75
Beta 0.598
Volatility 24.80%
Current Volume 1565.1k
Average Volume 20d 1240.8k
Stop Loss 27.1 (-3.2%)
Signal 0.89

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (20.3m TTM) > 0 and > 6% of Revenue (6% = 60.8m TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA 3.94pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -33.93% (prev -0.41%; Δ -33.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.13 (>3.0%) and CFO 401.4m > Net Income 20.3m (YES >=105%, WARN >=100%)
Net Debt (207.7m) to EBITDA (138.0m) ratio: 1.50 <= 3.0 (WARN <= 3.5)
Current Ratio 0.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (83.6m) change vs 12m ago -20.84% (target <= -2.0% for YES)
Gross Margin 72.47% (prev 62.78%; Δ 9.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 30.93% (prev 37.64%; Δ -6.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.18 (EBITDA TTM 138.0m / Interest Expense TTM 17.2m) >= 6 (WARN >= 3)

Altman Z'' -1.51

(A) -0.11 = (Total Current Assets 567.0m - Total Current Liabilities 910.6m) / Total Assets 3.12b
(B) -0.16 = Retained Earnings (Balance) -485.0m / Total Assets 3.12b
(C) 0.01 = EBIT TTM 20.4m / Avg Total Assets 3.27b
(D) -0.30 = Book Value of Equity -484.2m / Total Liabilities 1.59b
Total Rating: -1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 49.19

1. Piotroski 6.0pt = 1.0
2. FCF Yield 12.72% = 5.0
3. FCF Margin 31.48% = 7.50
4. Debt/Equity 0.19 = 2.48
5. Debt/Ebitda 1.50 = 0.95
6. ROIC - WACC (= -6.69)% = -8.36
7. RoE 1.21% = 0.10
8. Rev. Trend -74.36% = -5.58
9. EPS Trend -77.91% = -3.90

What is the price of PINC shares?

As of October 15, 2025, the stock is trading at USD 28.00 with a total of 1,565,069 shares traded.
Over the past week, the price has changed by +0.32%, over one month by +5.62%, over three months by +32.83% and over the past year by +50.17%.

Is Premier a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Premier (NASDAQ:PINC) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 49.19 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PINC is around 29.86 USD . This means that PINC is currently overvalued and has a potential downside of 6.64%.

Is PINC a buy, sell or hold?

Premier has received a consensus analysts rating of 2.88. Therefor, it is recommend to hold PINC.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 7
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the PINC price?

Issuer Target Up/Down from current
Wallstreet Target Price 28 -0.2%
Analysts Target Price 28 -0.2%
ValueRay Target Price 33 17.8%

Last update: 2025-10-02 02:25

PINC Fundamental Data Overview

Market Cap USD = 2.30b (2.30b USD * 1.0 USD.USD)
P/E Trailing = 40.8824
P/E Forward = 19.7239
P/S = 2.2699
P/B = 1.5023
P/EG = 1.6295
Beta = 0.598
Revenue TTM = 1.01b USD
EBIT TTM = 20.4m USD
EBITDA TTM = 138.0m USD
Long Term Debt = 2.01m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 289.4m USD (from shortTermDebt, last quarter)
Debt = 291.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 207.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.51b USD (2.30b + Debt 291.4m - CCE 83.7m)
Interest Coverage Ratio = 1.18 (Ebit TTM 20.4m / Interest Expense TTM 17.2m)
FCF Yield = 12.72% (FCF TTM 318.8m / Enterprise Value 2.51b)
FCF Margin = 31.48% (FCF TTM 318.8m / Revenue TTM 1.01b)
Net Margin = 2.00% (Net Income TTM 20.3m / Revenue TTM 1.01b)
Gross Margin = 72.47% ((Revenue TTM 1.01b - Cost of Revenue TTM 278.8m) / Revenue TTM)
Gross Margin QoQ = 71.93% (prev 73.90%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.51b / Total Assets 3.12b)
Interest Expense / Debt = 2.16% (Interest Expense 6.30m / Debt 291.4m)
Taxrate = 28.22% (7.08m / 25.1m)
NOPAT = 14.6m (EBIT 20.4m * (1 - 28.22%))
Current Ratio = 0.62 (Total Current Assets 567.0m / Total Current Liabilities 910.6m)
Debt / Equity = 0.19 (Debt 291.4m / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 1.50 (Net Debt 207.7m / EBITDA 138.0m)
Debt / FCF = 0.65 (Net Debt 207.7m / FCF TTM 318.8m)
Total Stockholder Equity = 1.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.65% (Net Income 20.3m / Total Assets 3.12b)
RoE = 1.21% (Net Income TTM 20.3m / Total Stockholder Equity 1.68b)
RoCE = 1.21% (EBIT 20.4m / Capital Employed (Equity 1.68b + L.T.Debt 2.01m))
RoIC = 0.78% (NOPAT 14.6m / Invested Capital 1.88b)
WACC = 7.47% (E(2.30b)/V(2.59b) * Re(8.22%) + D(291.4m)/V(2.59b) * Rd(2.16%) * (1-Tc(0.28)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -16.56%
[DCF Debug] Terminal Value 76.84% ; FCFE base≈277.4m ; Y1≈263.1m ; Y5≈251.0m
Fair Price DCF = 52.52 (DCF Value 4.34b / Shares Outstanding 82.7m; 5y FCF grow -6.72% → 3.0% )
EPS Correlation: -77.91 | EPS CAGR: -61.91% | SUE: -3.70 | # QB: 0
Revenue Correlation: -74.36 | Revenue CAGR: -6.25% | SUE: 0.97 | # QB: 1

Additional Sources for PINC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle